Differential diagnosis of fever in West- and East-Africa

Slides:



Advertisements
Similar presentations
By Gracie Canales August 10, 2010
Advertisements

Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.
Dr. Thaweesak Tirawatnapong Chula Medical Research Center (Chula MRC)
1.1.3 MI.
Pediatric Diagnosis of HIV-1 Infection Using Dried Blood Spots Chin-Yih Ou, PhD NCHSTP/DHAP Centers for Disease Control and Prevention.
Tropical Diseases Tropical diseases encompass all diseases that occur solely, or principally, in the tropics. In practice, the term is often taken to refer.
Role of the laboratory in disease surveillance
Alere TM HIV Combo Yuko Tamanoue, Product Development Department.
The Abaxis Piccolo xpress ™ The Advantage of Real Time Diagnostics.
World Health Organization
Parasitic protozoa of human importance : Disease : Malaria Agent : Plasmodium 4 species Differential pathogenicity Vector-borne Apicomplexan inhabiting.
Moving forward in the diagnosis of infectious diseases in developing countries: a focus on malaria Forum organized by Fondation Mérieux & the Roll Back.
Laboratory Investigation
Laboratory Training for Field Epidemiologists Polymerase Chain Reaction Investigation strategies and methods May 2007.
Ebola Virus Disease Clinical manifestations Ebola Virus Disease Clinical manifestations N. Shindo Lead, Clinical & Infection Control Pandemic & Epidemic.
CHIKUN GUNYA FEVER. INTRODUCTION  Caused by an Alpha Virus  Spread by bite of Aedes aegypti mosquito which usually bite during day light hours.  the.
Journal Club Capture and Ligation Probe-PCR (CLIP-PCR) for Molecular Screening, with Application to Active Malaria Surveillance for Elimination Z. Cheng,
Serum procalcitonin and C-reactive protein in children with community- acquired pneumonia K.Gogvadze, I.Guramishvili, I.Chkhaidze, K.Nemsadze, T.Maglakelidze.
Update on Assay Development George J. Dawson, Ph.D. Infectious Diseases: Core R & D Abbott Laboratories West Nile Virus.
EPIDEMIOLOGY DENGUE, MALARIA Priority Areas for Planning Dengue Emergency Response 1. Establish a multisectoral dengue action committee.
Parasitic protists of human importance : Disease : Malaria Agent : Plasmodium 4 species Differential pathogenicity Vector-borne Apicomplexan inhabiting.
Laboratory Results and Operations in WHO Phase 6 Dr. Attaporn Taweetungtragoon CYBELES Phnom Penh, Cambodia October 12-15, 2009.
Generic System for the Epidemiologic Surveillance of Dengue: Elaboration process Presented by: Dr. Gamaliel Gutiérrez Regional Dengue Program PAHO/WHO.
Fully-integrated microfluidic chips capable of performing DNA amplification from RNA virus, sample transportation, capillary electrophoresis separation,
CASE DETECTION by Dr Mikhail Ejov WHO Training in Malaria Elimination in the Greater Mekong Sub-Region, August 2015, Chiang Mai Thailand 1.
Malaria pan-R Malaria cassette. Agenda Disease overview Infectious agents Diagnosis pan-R Malaria cassette: specifications Conclusion.
The Factor II (Prothrombin) G20210A Detection and Genotyping
Dengue fever caused by dengue virus (DENV), a member of Flaviviridae leads to large global disease burden. Detection of immunoglobulin M (IgM) and nucleic.
BioPlex 2200 HIV Ag-Ab Assay
RESULTS Division of Arboviruses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for disease control, Osong, Korea BACKGROUND.
Dr Justin O’Grady. Zambia is a high burden TB and high HIV setting 44,154 TB cases notified in 2010 – incidence of 462/100,000 pop Approx 48% of pulmonary.
POSTER TEMPLATE BY: om EVALUATION OF A NEW ELISA DIAGNOSTIC KIT FOR CHIKUNGUNYA AND APPLICATION IN AN OUTBREAK SITUATION Caroline.
Diagnostic Testing for Zika Virus Frederick S. Nolte, PhD, D(ABMM), F(AAM) Professor and Vice-Chair for Laboratory Medicine Department of Pathology and.
Response to the Yellow Fever Outbreak in the WHO African Region: What has been done? Dr Ambrose Talisuna, WHO-Regional Office for Africa-AFRO Brazzaville-Congo.
Performance of a diagnostic test Tunisia, 31 Oct 2014
Erwan Piriou, PhD Laboratory advisor, Médecins Sans Frontières
Measles and Rubella Surveillance in the time of Zika: Brazil
Ebola Facts October 14, 2014.
Unexplained Neurologic Illness in Children – Malkangiri, Odisha, India, 2014 Authors: Priyakanta Nayak1, Mohan Papanna1, Aakash Shrivastava1, Pradeep.
J. Song, C. Liu, M. G. Mauk, S. C. Rankin,
Infectious Diseases Surveillance in the Military
Malaria Medicines and Diagnostics
From: Clinical and Laboratory Diagnosis of Dengue Virus Infection
FREQUENCIES AND PHENOTYPIC CHANGES OF DENDRITIC CELLS DURING ACUTE DENGUE VIRAL INFECTION Lertjuthaporn S1, Khowawisetsut L2, Keawvichit R1, Thitilertdecha.
ASM 2017 Microbe Annual Meeting Sunday-507
California Clinical Laboratory Association
Rapid Diagnosis of Dengue virus
Zhuoyu Ni¹†, Regina Heineman¹, Theron Gilliland, Jr
F. v. Stetten1,2, S. Haeberle1, D. Mark1, R. Zengerle1,2, J. Ducrée1
Molecular screening of Respiratory pathogens
Timely Diagnosis of Gastroenteritis: Implications for Patients and Public Health.
Ebola Facts October 14, 2014.
New STI diagnostics Nicola Low, Institute of Social and Preventive Medicine, University of Bern, Switzerland Sunday 22nd July, 2018, Session 7 Diagnostics.
Title Detection of HLA-B*58:01 with TaqMan assay and its association with allopurinol-induced sCADR.
Detection and Species Identification of Malaria Parasites by Isothermal tHDA Amplification Directly from Human Blood without Sample Preparation  Ying.
Ebola Facts October 14, 2014.
Development and Evaluation of a SYBR Green–Based Real-Time Multiplex RT-PCR Assay for Simultaneous Detection and Serotyping of Dengue and Chikungunya.
Molecular Diagnosis in Resource-Limited Settings Camilla Rodrigues, M
Nat. Rev. Urol. doi: /nrurol
DEVELOPMENT OF A NOVEL VNT ASSAY USING QRT-PCR-BASED ENDPOINT ASSESSMENT FOR RAPID DETECTION AND TITRATION OF NEUTRALIZING ANTIBODIES AGAINST FMDV.
Plasmodium Detection and Differentiation by Direct-on-Blood PCR Nucleic Acid Lateral Flow Immunoassay  Johanna M. Roth, Laura de Bes, Patrick Sawa, George.
ImmunoWELL Zika Virus Serology.
EPIDEMIOLOGY OF MALARIA BY MBBSPPT.COM
Workflow of a sample-to-answer AST performed in less than 30 min
1.1.3 MI.
Ebola Facts October 14, 2014.
Ebola Facts October 14, 2014.
Management Of Lassa Fever in a Resource Limited Setting: Experience From Irrua Specialist Teaching Hospital Main author: Gloria Esoimeme Co-authors:
PRACTICAL GUIDE THE PROCESS OF TESTING
The Company VOC Diagnostics AB
Presentation transcript:

Differential diagnosis of fever in West- and East-Africa S. Hin1, B. Lopez-Jimena3, M.A. Bakheit4, V. Klein2, S. Stack5, C. Fall6, A.A. Sall6, K. Enan7, S. Frischmann4, L. Gillies5, M. Weidmann3, S. Goethel8, V. Rusu8, O. Strohmeier1,2, N. Paust1,2, R. Zengerle1,2, K. Mitsakakis1,2,* 1 Laboratory for MEMS Applications, IMTEK - Department of Microsystems Engineering, University of Freiburg, Germany 2 Hahn-Schickard, Freiburg, Germany; 3 Institute of Aquaculture, University of Stirling, United Kingdom 4 MAST Diagnostica GmbH, Reinfeld, Germany; 5 Mast Group Limited, Liverpool, United Kingdom 6 Arbovirus and viral haemorrhagic fever unit, Institut Pasteur de Dakar, Dakar, Senegal 7 Central Laboratory, Khartoum, Sudan; 8 MagnaMedics Diagnostics BV, Geleen, The Netherlands * E-mail: konstantinos.mitsakakis@imtek.de Tel: +49 761 203 73252 Summary The FeverDisk point-of-care test detects on a single disposable cartridge and in a fully automated way, up to 12 fever-causing pathogens (viruses, bacteria, parasites) enabling, proper patient management and epidemics surveillance. L Motivation Acute fever is one of the most common symptoms among patients globally Diagnosis based merely on clinical symptoms is highly risky and inaccurate [1] Co-infections and epidemics outbreaks complicate the diagnostic landscape, often leading to wrong diagnosis and treatment [2] Proposed solution The FeverDisk as a point-of-care diagnostic tool [3] Results 50 disks @ Institut Pasteur de Dakar, Senegal [3] 15 disks @ Central Laboratory Khartoum, Sudan [3] Biobanked & fresh samples were used Conclusions Successful demonstration in operative environments Co-infections were detected (malaria/chikungunya & dengue/chikungunya) Unknown dengue serotype in sample was identified Positive and negative results on disk were confirmed by (RT)-qPCR, microscopy, lateral flow tests Capacity building of local personnel Acknowledgements / Disclosure This work was supported by the EC project DiscoGnosis (www.discognosis.eu) (FP7 GA-318408). We thank the Hahn-Schickard Lab-on-a-Chip Foundry Service for the production of the LabDisks. No conflict of interests is applicable. References [1] D’Acremont, V., et al., New England Journal of Medicine, 370, 2014, pp.809-817. [2] M. Amexo, et al., Lancet, 364, 2004, pp.1896-1898. [3] S. Hin/B. Lopez-Jimena, et al., in preparation. (A) (B) (C) Figure 3: (A) Packaged LabDisks ready for use. (B) Dr. Cheikh Fall using the LabDisk & Player at the Institut Pasteur de Dakar (March 2016. Source. Dr. B. Lopez-Jimena) Pan-malaria Chikungunya P. falciparum Dengue-2 Key parameters Performance features Multiplexed panel 12 targets simultaneously Sample volume 200 µL (blood, serum) Sample preparation In situ, all reagents for DNA/RNA extraction & purification are pre-stored Hands-on time < 5 min Total time-to-answer 70-120 min depending on the assay Amplification DNA/RNA: LAMP isothermal (primers and enzymes pre-stored) Stability studies Accelerated shelf life studies at > 90% humidity indicate 1.6 year stability @ 22oC Figure 4: Detection of double infection in biobanked sample in Dakar, Senegal. No unspecific amplification observed. Sample matrix: serum Figure 5: Detection of malaria in a real-time recruited patient in Central Laboratory Khartoum, Sudan. Sample matrix: whole blood NA.2 NA.3 NA.4 NA.1 Workflow step-by-step Sample addition in NA.1 Extraction and purification of pathogens’ DNA/RNA using pre-stored buffers (NA.2) Mixing with amplification enzymes (NA.3) Distribution to discrete reaction chambers (pre-stored primers offer specificity, NA.4) Isothermal amplification and real-time fluorescence signal detection (NA.4) Figure 1: The LabDisk used in the study Diagnostic panel of the FeverDisk (adaptable to end-users’ needs) Bacteria S. Typhi S. Paratyphi S. pneumoniae Parasites Pan malaria screening P. falciparum P. malariae P. vivax Viruses Dengue (1-4) Chikungunya Zika Febrile patient & antimicrobial resistance management Early epidemics identification & surveillance Vector control, disease data management Figure 2: Clinical utility and diagnostic impact of the FeverDisk